Veeva Systems (VEEV): are the analysts right?

Veeva Systems · Health Care · ref. ETF XLV · 86 calls · price $192.3
What the company does: Veeva Systems fournit un logiciel basé sur le cloud pour l'industrie des sciences de la vie mondialement.
📈 1-year price
$192.3-31.5% over range
Jul 8, 25low $151.43 · high $306.22Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
65% recommend buying · 20 analysts

🎯 Analyst price target on VEEV

High target · 1 analyst$340+76.8%
Median target · 20 analysts$235+22.2%
Low target · 1 analyst$165-14.2%
Current price$192.3

🗳️ The analyst consensus

Analyst breakdown · 20 (6 months)
Strong Buy0%
Buy65%
Hold30%
Sell5%
Strong Sell0%

✅ Historical analyst reliability on VEEV

Most reliable analysts on VEEV (% profitable · 365j · ≥2 calls)
Piper Sandler 67% +16.5% 12
Needham 58% +16.1% 12
Baird 50% +12.8% 12

📊 What $1,000 invested in Veeva Systems would be worth

In short — $1,000 invested in Veeva Systems 10 years ago would be worth $6,151 today, i.e. +20%/yr on average. Best year: 2020 (+94%), worst: 2022 (-37%). Price performance, excluding dividends.

If I'd invested $1,000 in Veeva Systems

InvestmentWorth todayGain
1 years ago$844-16%
3 years ago$1,100+10%
5 years ago$652-35%
10 years ago$6,151+515%
since inception (2013)$4,383+338%

Return by year (Veeva Systems)

YearReturn$1,000 invested at year start
2026 (YTD)-20%$795 (-20%)
2025+6%$844 (-16%)
2024+9%$922 (-8%)
2023+19%$1,100 (+10%)
2022-37%$695 (-31%)
2021-6%$652 (-35%)
2020+94%$1,262 (+26%)
2019+57%$1,987 (+99%)
2018+62%$3,210 (+221%)
2017+36%$4,360 (+336%)
2016+41%$6,151 (+515%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on VEEV

Citigroup
Jun 4, 26
■ Neutral neutral · not a buy · 🎯$190
Price at call : $172.61 — gap to target +10%
Today : $192.3 — gap to target -1%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jun 4, 27
Mizuho
Jun 4, 26
▲ Outperform · 🎯$270
Price at call : $172.61 — upside +56%
Today : $192.3 — upside +40%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Jun 4, 27
▼ Sell · 🎯$165
Price at call : $172.61 — upside -4%
Today : $192.3 — upside -14%
🎯 on VEEV : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Jun 4, 27
Oppenheimer
Jun 4, 26
▲ Outperform · 🎯$225
Price at call : $172.61 — upside +30%
Today : $192.3 — upside +17%
🎯 on VEEV : no call matured yet · 📊 on Health : 43.5% · -0.4% (216 calls)
in progress (365j)
matures : Jun 4, 27
■ Hold neutral · not a buy · 🎯$220
Price at call : $172.61 — gap to target +27%
Today : $192.3 — gap to target +14%
🎯 on VEEV : no call matured yet · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : Jun 4, 27
Stifel
Jun 4, 26
▲ Buy · 🎯$230
Price at call : $172.61 — upside +33%
Today : $192.3 — upside +20%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Jun 4, 27
■ In-Line neutral · not a buy · 🎯$185
Price at call : $172.61 — gap to target +7%
Today : $192.3 — gap to target -4%
🎯 on VEEV : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jun 4, 27
UBS
Jun 4, 26
■ Neutral neutral · not a buy · 🎯$190
Price at call : $172.61 — gap to target +10%
Today : $192.3 — gap to target -1%
🎯 on VEEV : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Jun 4, 27
RBC Capital
Jun 4, 26
▲ Outperform · 🎯$275
Price at call : $172.61 — upside +59%
Today : $192.3 — upside +43%
🎯 on VEEV : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Jun 4, 27
BMO Capital
Jun 4, 26
■ Market Perform neutral · not a buy · 🎯$175
Price at call : $178.6 — gap to target -2%
Today : $192.3 — gap to target -9%
🎯 on VEEV : no call matured yet · 📊 on Health : 60.9% · +9.2% (235 calls)
in progress (365j)
matures : Jun 4, 27
Wells Fargo
Jun 4, 26
▲ Overweight · 🎯$320
Price at call : $178.6 — upside +79%
Today : $192.3 — upside +66%
🎯 on VEEV : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Jun 4, 27
Barclays
Jun 4, 26
▲ Overweight · 🎯$235
Price at call : $178.6 — upside +32%
Today : $192.3 — upside +22%
🎯 on VEEV : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Jun 4, 27
Baird
Jun 4, 26
▲ Outperform · 🎯$260
Price at call : $178.6 — upside +46%
Today : $192.3 — upside +35%
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Jun 4, 27
BTIG
Jun 4, 26
▲ Buy · 🎯$340
Price at call : $178.6 — upside +90%
Today : $192.3 — upside +77%
🎯 on VEEV : no call matured yet · 📊 on Health : 56.2% · +9.8% (112 calls)
in progress (365j)
matures : Jun 4, 27
Needham
Jun 4, 26
▲ Buy · 🎯$270
Price at call : $178.6 — upside +51%
Today : $192.3 — upside +40%
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Jun 4, 27
▲ Overweight · 🎯$235
Price at call : $178.6 — upside +32%
Today : $192.3 — upside +22%
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Jun 4, 27
Oppenheimer
May 18, 26
▲ Outperform · 🎯$225
Price at call : $163.85 — upside +37%
Today : $192.3 — upside +17%
🎯 on VEEV : no call matured yet · 📊 on Health : 43.5% · -0.4% (216 calls)
in progress (365j)
matures : May 18, 27
Citigroup
Apr 10, 26
■ Neutral neutral · not a buy · 🎯$176
Price at call : $158.45 — gap to target +11%
Today : $192.3 — gap to target -8%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Apr 10, 27
Citigroup
Mar 9, 26
▲ Buy · 🎯$291
Price at call : $189.69 — upside +53%
Today : $192.3 — upside +51%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Mar 9, 27
■ Hold neutral · not a buy · 🎯$235
Price at call : $195.49 — gap to target +20%
Today : $192.3 — gap to target +22%
🎯 on VEEV : no call matured yet · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : Mar 5, 27
TD Cowen
Mar 5, 26
▲ Buy · 🎯$300
Price at call : $195.49 — upside +53%
Today : $192.3 — upside +56%
🎯 on VEEV : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Mar 5, 27
Wells Fargo
Mar 5, 26
▲ Overweight · 🎯$317
Price at call : $195.49 — upside +62%
Today : $192.3 — upside +65%
🎯 on VEEV : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Mar 5, 27
Stifel
Mar 5, 26
▲ Buy · 🎯$245
Price at call : $195.49 — upside +25%
Today : $192.3 — upside +27%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Mar 5, 27
▲ Buy · 🎯$262
Price at call : $195.49 — upside +34%
Today : $192.3 — upside +36%
🎯 on VEEV : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Mar 5, 27
RBC Capital
Mar 5, 26
▲ Outperform · 🎯$275
Price at call : $195.49 — upside +41%
Today : $192.3 — upside +43%
🎯 on VEEV : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Mar 5, 27
UBS
Mar 5, 26
■ Neutral neutral · not a buy · 🎯$220
Price at call : $195.49 — gap to target +13%
Today : $192.3 — gap to target +14%
🎯 on VEEV : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Mar 5, 27
■ In-Line neutral · not a buy · 🎯$240
Price at call : $195.49 — gap to target +23%
Today : $192.3 — gap to target +25%
🎯 on VEEV : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Mar 5, 27
■ Equal-Weight neutral · not a buy · 🎯$215
Price at call : $196.06 — gap to target +10%
Today : $192.3 — gap to target +12%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Mar 5, 27
Needham
Mar 5, 26
▲ Buy · 🎯$270
Price at call : $196.06 — upside +38%
Today : $192.3 — upside +40%
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Mar 5, 27
▲ Overweight · 🎯$285
Price at call : $196.06 — upside +45%
Today : $192.3 — upside +48%
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Mar 5, 27
Stifel
Feb 26, 26
▲ Buy · 🎯$212
Price at call : $182.01 — upside +16%
Today : $192.3 — upside +10%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Feb 26, 27
Barclays
Feb 25, 26
▲ Overweight · 🎯$250
Price at call : $182.86 — upside +37%
Today : $192.3 — upside +30%
🎯 on VEEV : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 25, 27
Oppenheimer
Feb 24, 26
▲ Outperform · 🎯$275
Price at call : $176.46 — upside +56%
Today : $192.3 — upside +43%
🎯 on VEEV : no call matured yet · 📊 on Health : 43.5% · -0.4% (216 calls)
in progress (365j)
matures : Feb 24, 27
JP Morgan
Feb 20, 26
▲ Overweight · 🎯$296
Price at call : $172.17 — upside +72%
Today : $192.3 — upside +54%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Feb 20, 27
UBS
Feb 20, 26
■ Neutral neutral · not a buy · 🎯$200
Price at call : $172.17 — gap to target +16%
Today : $192.3 — gap to target +4%
🎯 on VEEV : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Feb 20, 27
■ Equal-Weight neutral · not a buy · 🎯$205
Price at call : $176.82 — gap to target +16%
Today : $192.3 — gap to target +7%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Feb 17, 27
Keybanc
Dec 12, 25
■ Sector Weight neutral · not a buy
🎯 on VEEV : no call matured yet · 📊 on Health : 44.6% · -1.1% (139 calls)
in progress (365j)
matures : Dec 12, 26
Wells Fargo
Nov 25, 25
▲ Overweight · 🎯$333
Price at call : $240.67 — upside +38%
Today : $192.3 — upside +73%
🎯 on VEEV : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Nov 25, 26
Citigroup
Nov 24, 25
▲ Buy · 🎯$319
Price at call : $239.95 — upside +33%
Today : $192.3 — upside +66%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Nov 24, 26
■ Hold neutral · not a buy · 🎯$280
Price at call : $235.74 — gap to target +19%
Today : $192.3 — gap to target +46%
🎯 on VEEV : no call matured yet · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : Nov 21, 26
Barclays
Nov 21, 25
▲ Overweight · 🎯$305
Price at call : $235.74 — upside +29%
Today : $192.3 — upside +59%
🎯 on VEEV : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Nov 21, 26
UBS
Nov 21, 25
■ Neutral neutral · not a buy · 🎯$280
Price at call : $235.74 — gap to target +19%
Today : $192.3 — gap to target +46%
🎯 on VEEV : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Nov 21, 26
Baird
Nov 21, 25
▲ Outperform · 🎯$319
Price at call : $244.06 — upside +31%
Today : $192.3 — upside +66%
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Nov 21, 26
Needham
Nov 21, 25
▲ Buy · 🎯$355
Price at call : $244.06 — upside +45%
Today : $192.3 — upside +85%
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Nov 21, 26
BTIG
Nov 21, 25
▲ Buy · 🎯$340
Price at call : $244.06 — upside +39%
Today : $192.3 — upside +77%
🎯 on VEEV : no call matured yet · 📊 on Health : 56.2% · +9.8% (112 calls)
in progress (365j)
matures : Nov 21, 26
BMO Capital
Nov 13, 25
■ Market Perform neutral · not a buy · 🎯$300
Price at call : $291.7 — gap to target +3%
Today : $192.3 — gap to target +56%
🎯 on VEEV : no call matured yet · 📊 on Health : 60.9% · +9.2% (235 calls)
in progress (365j)
matures : Nov 13, 26
Needham
Oct 17, 25
▲ Buy · 🎯$355
Price at call : $283.73 — upside +25%
Today : $192.3 — upside +85%
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Oct 17, 26
BTIG
Oct 17, 25
▲ Buy · 🎯$340
Price at call : $283.73 — upside +20%
Today : $192.3 — upside +77%
🎯 on VEEV : no call matured yet · 📊 on Health : 56.2% · +9.8% (112 calls)
in progress (365j)
matures : Oct 17, 26
TD Cowen
Oct 7, 25
▲ Buy · 🎯$380
Price at call : $301.8 — upside +26%
Today : $192.3 — upside +98%
🎯 on VEEV : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Oct 7, 26
JP Morgan
Sep 8, 25
▲ Overweight · 🎯$330
Price at call : $282.78 — upside +17%
Today : $192.3 — upside +72%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Sep 8, 26
Piper Sandler
May 29, 25
▲ Overweight · 🎯$325
Price at call : $279.7 — upside +16%
Today : $192.3 — upside +69%
Expected +16% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
-32.6%
stock -33% · XLV +11%
Needham
May 29, 25
▲ Buy · 🎯$300
Price at call : $279.04 — upside +8%
Today : $192.3 — upside +56%
Expected +8% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
-37.5%
stock -38% · XLV +13%
Piper Sandler
Apr 23, 25
▲ Overweight · 🎯$255
Price at call : $227.71 — upside +12%
Today : $192.3 — upside +33%
Expected +12% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
-29.2%
stock -29% · XLV +5%
Baird
Mar 6, 25
▲ Outperform · 🎯$285
Price at call : $236.14 — upside +21%
Today : $192.3 — upside +48%
Expected +21% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
-17.2%
stock -17% · XLV +2%
Needham
Mar 6, 25
▲ Buy · 🎯$270
Price at call : $236.14 — upside +14%
Today : $192.3 — upside +40%
Expected +14% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
-17.2%
stock -17% · XLV +2%
Needham
Jan 17, 25
▲ Buy · 🎯$270
Price at call : $216.59 — upside +25%
Today : $192.3 — upside +40%
Expected +25% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
-0.1%
stock -0% · XLV +11%
Baird
Dec 6, 24
▲ Outperform · 🎯$283
Price at call : $250.45 — upside +13%
Today : $192.3 — upside +47%
Expected +13% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
-4.5%
stock -5% · XLV +5%
Needham
Dec 6, 24
▲ Buy · 🎯$270
Price at call : $250.45 — upside +8%
Today : $192.3 — upside +40%
Expected +8% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
-4.5%
stock -5% · XLV +5%
▲ Overweight · 🎯$290
Price at call : $250.45 — upside +16%
Today : $192.3 — upside +51%
Expected +16% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
-4.5%
stock -5% · XLV +5%
Needham
Nov 8, 24
▲ Buy · 🎯$260
Price at call : $235 — upside +11%
Today : $192.3 — upside +35%
Expected +11% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
+25.9%
stock +26% · XLV -2%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)